5 European Projects Found
Searched on 125080 European Projects
FINISHED
NanoBioEngineering of BioInspired BioPolymers (Nano3Bio)
Start date: Oct 1, 2013, End date: Sep 30, 2017,
The Nano3Bio project convenes a consortium of world renowned experts from 8 EU universities, 1 large company, and 14 SME, to develop biotechnological production systems for nanoformulated chitosans. Chitosans, chitin-derived polysaccharides varying in their degree of polymerisation (DP), degree of acetylation (DA), and pattern of acetylation (PA), are among the most versatile and most promising bi ...
Read Project
23
Partners Participants
FINISHED
Synthetic biology – Engaging with New and Emerging Science and Technology in Responsible Governance of the Science and Society Relationship (SYN-ENERGENE)
Start date: Jul 1, 2013, End date: Jun 30, 2017,
Synthetic biology (SynBio) offers huge potential for applications in energy, health and the environment. It also brings with it various challenges such as regulatory issues of biosafety, biosecurity and intellectual property rights, as well as potential environmental and socio-economic risks in developing countries. As yet, however, there is scant public knowledge about the technology. It is thus ...
Read Project
29
Partners Participants
FINISHED
Cutaneous and Mucosal HIV Vaccination (CUT'HIVAC)
Start date: Jan 1, 2010, End date: Dec 31, 2015,
Despite significant effort over the past decade to design and implement new vaccines strategies against HIV, no one has met its promise to prevent infection and/or to reduce viral load until reaching eradication of the HIV reservoir. To reach this goal, a translational research is critical to propose innovative approaches for an HIV vaccine enhancing broadly cross-reactive mucosal, humoral and cel ...
Read Project
18
Partners Participants
FINISHED
EUROpean consortium on NEUTralising antibodies using gp41 (EURONEUT-41)
Start date: Jan 1, 2008, End date: Mar 31, 2014,
There is now an increasingly solid body of scientific evidence which demonstrates that the binding of small molecular weight compounds, peptides and antibodies (Abs) to fusion-intermediate conformations of gp41 leads to an inhibition of HIV cell entry. The principal aim of this project is to exploit this information by establishing a platform where gp41-derived vaccine candidates will be designed ...
Read Project
19
Partners Participants
FINISHED
Novel Polysaccharide Modifying Enzymes to Optimise the Potential of Hydrocolloids for Food and Medical Applications (PolyModE)
Start date: May 1, 2009, End date: Apr 30, 2013,
The PolyModE project convenes an international, interdisciplinary, and intersectorial consortium to identify, characterise, and optimise novel polysaccharide modifying enzymes, and to develop robust fermentation strategies for their large-scale production, to exploit the potential of biopolymers for food, pharmaceutical, cosmetic, and technical applications. We have selected the six complex carboh ...
Read Project
